glp-1 receptor agonists brand names How medications are transforming diabetes and weight loss treatment 5 GLP-1 trends to expect

JAMA Neurol 76(4):420429 Brown JC, Dryburgh JR (1971) A gastric inhibitory polypeptide II: the complete amino acid sequence

Compounded medications are not FDA-approved and are prepared by licensed compounding pharmacies

A full overview of the indications of the specific treatments has been described in recent guidelines (McDonagh et al., 2021

Although the impact of GLP-1RAs on pancreatic cancer risk remains controversial, emerging evidence suggests that chronic low-grade inflammation and proliferative changes may constitute key pathophysiological mechanisms underlying pancreatic cancer development in patients receiving GLP-1RA therapy [8]

doi: 10.1080/03007995.2018.1465903

Discussion The present network meta-analysis included the most recent published CVOTs, thus providing the most contemporary assessment of the total available evidence for DPP-4 inhibitors, GLP-1RA and SGLT-2 inhibitors and their cardiorenal outcomes